SOAT1 and primary cutaneous T-cell non-Hodgkin lymphoma: We also discuss five agents with inhibitory effects on the JAK/STAT pathway (ND16, ECPIRM [a 13-cis retinoic acid derivative], Tyrphostin AG490, Cucurbitacin, and Pimozide) that have been studied in vitro or in vivo in murine models of CTCL.